Ho, G.Y.F., Bierman, R., Beardsley, L., C.J. Chang, and Burk, R.D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428, 1998.
Schoenfeld, A., Davidowitz, E.J. and Burk, R.D.A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.
Proc. Natl. Acad. Sci. 95:8817-8822, 1998.
Burk, R.D. Pernicious papillomavirus infection. N. Engl. J. Med. 341:1687-1688, 1999.
Davidowitz, E.J., Schoenfeld, A.R. and Burk, R.D. VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-ECM signaling. Mol. Cell. Biol. 21:865-874, 2001.
Cotter, M.P., Gern, R.W., Ho, G.Y.F., R.Y. and Burk, R.D. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate 50:216-221, 2002.
Ho, G.Y.F., Studentsov, Y., Biermann, R., Beardsley, L., Lempa, M., and Burk, R.D. Risk factors for subsequent cervicovaginal human papillomavirus infection and the protective role of HPV16 VLP antibodies. J. Infect. Dis. 186:737-742, 2002.
Mohan, S. and Burk, R.D. von Hippel-Lindau protein complex is regulated by cell density.
Oncogene 22:5270-5280, 2003.
Strickler, H.D., Palefsky, J.M., Shah, K.V., Anastos, K., Klein, R.S., Minkoff, H., Duerr, A., Massad, S., Celentano, D.D., Hall, C., Fazzari, M., Cu-Uvin, S., Bacon, M., Schuman, P., Levine, A.M., Durante, A.J., Gange, S., Melnick, S. and Burk, R.D. Human papillomavirus 16 and immune status in human immunodeficiency virus-seropositive women. J. Natl. Cancer Inst. 95:1062-1071, 2003.
Ho, G.Y.F., Studentsov, Y., Biermann, R. and Burk, R.D.Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol. Biomarkers Prev. 13:110-116, 2004.
Chen, Z., Terai, M., Fu, L., Herrero, R., DeSalle, R. and Burk, R.D.Diversifying selection in human papillomavirus type 16 (HPV16) lineages based on complete genome analysis.
>J. Virol. 79:7014-7023, 2005.
Herrero, R., Castle, P.E., Schiffman, M., Bratti, C., Hildesheim, A., Morales, J., Sherman, M.E., Wacholder, S., Alfaro, M., Rodríguez, A.C. and Epidemiologic profile of type-specific HPV infection and cervical neoplasia in Guanacaste. J. Infect. Dis. 191:1796-1807, 2005.
Schiffman, M., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Rodriguez, A.C., Bratti, M.C., Sherman, M.E., Morales, J., Guillen, D., Alfaro, M., Hutchinson, M., Wright, T.C., Solomon, D., Chen, Z., Schussler, J., Castle, P.E. andBurk, R.D. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337:76-84, 2005.
Narechania, A., Chen, Z., DeSalle, R. and Burk, R.D. Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J. Virol. 79:15503-15510, 2005.
Lutz, M.S. and Burk, R.D. Primary cilium formation requires von Hippel-Lindau gene function in renal derived cells. Cancer Res. 66:6903-6907, 2006. (Highlighted article in July 15, 2007 Cancer Res.).
Burk, R.D.and DeSalle, R. The tango and tangle of human papillomavirus and the human genome.J. Natl. Cancer Inst. 98:1026-7, 2006 (editorial).
16.Butsch Kovacic, M., Castle, P.E., Herrero, R., Schiffman, M., Sherman, M.E., Wacholder, S., Rodriguez, A.C., Hutchinson, M.L., Concepción Bratti, M., Hildesheim, A., Morales, J., Alfaro, M. and Burk, R.D.Relationships of human papillomavirus type, qualitative viral load & age to cytologic abnormality. Cancer Res. 66:10112-10119, 2006.
Burk, R.D.Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45. Int. J. Cancer 121:2947-2952, 2007.
Wood, C.E., Chen, Z., Cline, J.M., Miller, B.E. and Burk, R.D.Characterization and experimental transmission of an oncogenic papillomavirus in female macaques.
J. Virol. 81:6339-6345, 2007. (Spotlight of June 2007 J. Virol. Issue).
Kahn, J.A. andBurk, R.D.Papillomavirus vaccines in perspective.
Lancet 369:2135-7, 2007 (comment).
20.Chen, Z., DeSalle, R., Schiffman, M., Herrero, R. and Burk, R.D.Evolutionary dynamics of human papillomavirus types 18, 45 and 97 variant genomes. J. Virol. 83:1443-1455, 2009.
21.Agalliu, I., Gern, R., Leanza, S. andBurk, R.D.Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clinical Cancer Res. 15:1112-1120, 2009.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.